Neuromyelitis optica (NMOSD): open trials in Argentina

• NCT05966467

  Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies

  Research · Alexion Pharmaceuticals, Inc.

  Buenos Aires

  Registry updated 2026-10-13

• NCT05199688

  A Study to Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, and Pharmacodynamics of Satralizumab in Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)

  Trial Treatment · Phase 3 · Hoffmann-La Roche

  Hospital de Pediatría S.A.M.I.C.- Prof. Dr. Juan P. Garrahan, Ciudad Autonoma Buenos Aires · Clínica Universitaria Reina Fabiola, Córdoba

  Registry updated 2026-10-01

• NCT05549258

  Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder

  Trial Treatment · Phase 2 · Amgen

  Hospital de Pediatría S.A.M.I.C.- Prof. Dr. Juan P. Garrahan, Parque Patricios

  Registry updated 2025-12-05

All Neuromyelitis optica (NMOSD) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error